Clinical trial
The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia
NCT00148447 · BeerYaakov Mental Health Center, Other · Completed
Key facts
| NCT number | NCT00148447 |
|---|---|
| Title | The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia |
| Official title | Placebo-Controlled Trial of Cipralex in the Treatment of Negative Symptoms in Schizophrenia |
| Lead sponsor | BeerYaakov Mental Health Center, Other |
| Collaborators | Lundbeck Israel Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | escitalopram |
| Enrollment | 40 |
| Start date | Nov 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Sep 8, 2005 |
| Last update posted | May 3, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: